Updates in the Management of Gout

American Journal of Medicine

Volumn 120, Issue 3, 2007, Pages 221-224

  Keith, Michael P ^a   Gilliland, William R ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Colchicine; Febuxostat; Gout; Management; Nonsteroidal anti inflammatory agents; Probenecid; Xanthine oxidase

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; ASCORBIC ACID; AZATHIOPRINE; BENZBROMARONE; COLCHICINE; CORTICOSTEROID; CORTICOTROPIN; CYCLOSPORIN; ETHAMBUTOL; FEBUXOSTAT; FUROSEMIDE; INDOMETACIN; LIDOCAINE; MERCAPTOPURINE; METHYLPREDNISOLONE; NAPROXEN; NICOTINIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; OXIPURINOL; PREDNISONE; PROBENECID; PYRAZINAMIDE; SULFINPYRAZONE; THIAZIDE DIURETIC AGENT; TRIAMCINOLONE; UNINDEXED DRUG; URIC ACID; URICOSURIC AGENT; XANTHINE OXIDASE INHIBITOR;

ABDOMINAL PAIN; ARTICLE; BONE MARROW SUPPRESSION; COMORBIDITY; CREATINE KINASE BLOOD LEVEL; DIARRHEA; DISEASE COURSE; DRUG COST; DRUG DOSE REDUCTION; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; EOSINOPHILIA; FEVER; GASTROINTESTINAL SYMPTOM; GOUT; HEPATITIS; HUMAN; HYPERURICEMIA; KIDNEY FAILURE; LIFESTYLE MODIFICATION; MUSCLE WEAKNESS; MYOPATHY; NAUSEA; NEPHROLITHIASIS; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RASH; REPEATED DRUG DOSE; SIDE EFFECT; TOXIC EPIDERMAL NECROLYSIS; TREATMENT INDICATION; VASCULITIS;

EID: 33847386196     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2006.02.044     Document Type: Note

References (9)

1. Champion E.W., Glynn R.J., and DeLabry L.O. Asymptomatic hyperuricemia: risks and consequences in the normative Aging Study. Am J Med 82 (1987) 421-426
2. Wortmann R.L. Recent advances in the management of gout and hyperuricemia. Curr Opin Rheumatol 17 (2005) 319-324
3. Wilbur K., and Makowsky M. Colchicine myotoxicity: case reports and literature review. Pharmacotherapy 24 (2004) 1784-1792
4. Getting S.J., Christian H.C., Flower R.J., et al. Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. Arthritis Rheum 46 (2002) 2765-2775
5. Shoji A., Yamanaka H., and Kamatani N. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum 51 (2004) 321-325
6. Becker M.A., Schumacher Jr. H.R., Wortmann R.L., et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 353 (2005) 2450-2461
7. Fam A.G., Dunne S.M., Iazzetta J., et al. Efficacy and safety of desensitization to allopurinol following cutaneous reactions. Arthritis Rheum 44 (2001) 231-238
8. Huang H.Y., Appel L.J., Choi M.J., et al. The effects of vitamin C supplementation on serum concentrations of uric acid: a randomized controlled trial. Arthritis Rheum 52 (2005) 1843-1847
9. Chin M.H., Wang L.C., Jin L., et al. Appropriateness of medication selection for older persons in an urban academic emergency department. Acad Emerg Med 6 12 (1999) 1189-1193